Enanta Pharmaceuticals
ENTA
#7974
Rank
NZ$0.63 B
Marketcap
NZ$21.99
Share price
-1.31%
Change (1 day)
64.84%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : NZ$0.34 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total liabilities are NZ$0.34 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enanta Pharmaceuticals - Total liabilities on balance sheet (from 2011 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-09-30NZ$0.37 B-4.58%
2024-09-30NZ$0.39 B-4.64%
2023-09-30NZ$0.40 B326.94%
2022-09-30NZ$95.93 M68.09%
2021-09-30NZ$57.07 M23.72%
2020-09-30NZ$46.13 M5.68%
2019-09-30NZ$43.65 M40.71%
2018-09-30NZ$31.02 M-10.62%
2017-09-30NZ$34.7 M122.19%
2016-09-30NZ$15.62 M1.26%
2015-09-30NZ$15.42 M78.17%
2014-09-30NZ$8.65 M10.41%
2013-09-30NZ$7.84 M-21.15%
2012-09-30NZ$9.94 M84.28%
2011-09-30NZ$5.39 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$206.01 B 60,322.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$137.00 B 40,080.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$246.23 B 72,117.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$12.25 B 3,495.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$142.41 B 41,670.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$114.22 B 33,402.43%๐Ÿ‡บ๐Ÿ‡ธ USA